BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Hct116 Cells

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Hct116 Cells:

Pubmed Logo
HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21.
Monitoring Editor: John L. Cleveland The class II HDAC, HDAC4, is...
18th July, 2008
Department of Oncology, Albert Einstein Cancer Center, Montefiore Medical Mol Biol Cell. 2008 Jul 16;.
DOI Direct Link
CTCFL/BORIS is a methylation-independent DNA-binding protein that preferentially binds to the paternal H19 differentially methylated region.
The CTCF paralog BORIS (brother of the regulator of imprinted sites) is an...
18th July, 2008
Radiation Oncology Branch, Center for Cancer Research, National Cancer Cancer Res. 2008 Jul 15;68(14):5546-51.
DOI Direct Link
Antibody Targeting of Camptothecin-Loaded PLGA Nanoparticles to Tumor Cells.
Antibody targeting of drug substances can improve the efficacy of the...
17th July, 2008
School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Bioconjug Chem. 2008 Jul 16;.
DOI Direct Link
Reactive oxygen species-mediated cyclin D1 degradation mediates tumor growth retardation in hypoxia, independently of p21(cip1) and hypoxia-inducible factor.
Cell growth arrest is an adaptation process for tumor survival in hypoxic...
12th July, 2008
Department of Pharmacology, Seoul National University College of Medicine, Cancer Sci. 2008 Jun 30;.
DOI Direct Link
Stably transfected common fragile site sequences exhibit instability at ectopic sites.
Common fragile sites (CFSs) are loci that are especially prone to forming...
11th July, 2008
Department of Human Genetics, University of Michigan, Ann Arbor, MI. Genes Chromosomes Cancer. 2008 Jul 9;.
DOI Direct Link

View more research publications.

BioNews Results for Hct116 Cells:

RSS Logo
BioPortfolio Logo
Securin is required for chromosomal stability in human cells
PharmCast:  Apr 24 2008 12:13PM Matching: hct116 cells

Hct116 Cells Patents:

USPTO Logo
US Patent No.Title
7148009 Cancer drug screen based on cell cycle uncoupling
7196068 Method for treating cancer using p38/JTV-1 and method for screening pharmaceutical composition for treating cancer
7205326 Aniline derivatives, their manufacture and use as pharmaceutical agents
7214480 Methods and compositions for diagnosing and suppressing metastasis thereof
7214660 Erythropoietin: remodeling and glycoconjugation of erythropoietin

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Hct116 Cells scientists - we have details of around 91 individuals working on Hct116 Cells .


This page has been viewed 111 times
Recent Search Terms used to find this page: hct116 | HCT 116 | pten and HCT116 | hct116 wikipedia | HCT116 | HCT116 | HCT116 wikipedia | hct116 | hct116 stimulating | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Hct116 Cells across BioPortfolio, or bestselling Hct116 Cells books or recently published Hct116 Cells books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional